These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16500905)

  • 1. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis.
    Das P; Ng AK; Earle CC; Mauch PM; Kuntz KM
    Ann Oncol; 2006 May; 17(5):785-93. PubMed ID: 16500905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
    Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
    Mahadevia PJ; Fleisher LA; Frick KD; Eng J; Goodman SN; Powe NR
    JAMA; 2003 Jan; 289(3):313-22. PubMed ID: 12525232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.
    Guadagnolo BA; Punglia RS; Kuntz KM; Mauch PM; Ng AK
    J Clin Oncol; 2006 Sep; 24(25):4116-22. PubMed ID: 16943528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of Lung Cancer Screening in Canada.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
    Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
    Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.
    Chen AB; Punglia RS; Kuntz KM; Mauch PM; Ng AK
    J Clin Oncol; 2009 Nov; 27(32):5383-9. PubMed ID: 19752333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of computed tomography screening for lung cancer in the United States.
    McMahon PM; Kong CY; Bouzan C; Weinstein MC; Cipriano LE; Tramontano AC; Johnson BE; Weeks JC; Gazelle GS
    J Thorac Oncol; 2011 Nov; 6(11):1841-8. PubMed ID: 21892105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model.
    Kent MS; Korn P; Port JL; Lee PC; Altorki NK; Korst RJ
    Ann Thorac Surg; 2005 Oct; 80(4):1215-22; discussion 1222-3. PubMed ID: 16181843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
    Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
    Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
    Kowada A
    BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening.
    Wisnivesky JP; Mushlin AI; Sicherman N; Henschke C
    Chest; 2003 Aug; 124(2):614-21. PubMed ID: 12907551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic decision analysis model of screening for lung cancer.
    Marshall D; Simpson KN; Earle CC; Chu CW
    Eur J Cancer; 2001 Sep; 37(14):1759-67. PubMed ID: 11549429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions.
    Villanti AC; Jiang Y; Abrams DB; Pyenson BS
    PLoS One; 2013; 8(8):e71379. PubMed ID: 23940744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
    van Loon J; Grutters JP; Wanders R; Boersma L; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Brans B; Snoep G; Hochstenbag M; Lambin P; De Ruysscher D
    Eur J Cancer; 2010 Jan; 46(1):110-9. PubMed ID: 19944595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional Computed Tomographic Calcium Scoring vs full chest CTCS for lung cancer screening: a cost-effectiveness analysis.
    Jiang B; Linden PA; Gupta A; Jarrett C; Worrell SG; Ho VP; Perry Y; Towe CW;
    BMC Pulm Med; 2020 Jul; 20(1):187. PubMed ID: 32631384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.